Most cited papers from IQ Solutions

IQ Solutions

What are the most cited papers from IQ Solutions?

The most cited paper from IQ Solutions is "SciPy 1.0: fundamental algorithms for scientific computing in Python" (Pauli Virtanen et al., 2020), with 40,161 citations. Next come "Epidemiology of Ankle Sprains and Chronic Ankle Instability" (658) and "Characterizing treatment pathways at scale using the OHDSI network" (351).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 33 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	SciPy 1.0: fundamental algorithms for scientific computing in Python Pauli Virtanen et al. · Nature Methods Open access112 authors	3 Feb 2020	40,161
2	Epidemiology of Ankle Sprains and Chronic Ankle Instability Mackenzie M. Herzog, Zachary Y. Kerr, Stephen W. Marshall et al. · Journal of Athletic Training Open access	28 May 2019	658
3	Characterizing treatment pathways at scale using the OHDSI network George M. Hripcsak, Patrick B. Ryan, Jon D Duke et al. · Proceedings of the National Academy of Sciences Open access	6 Jun 2016	351
4	Trial designs using real‐world data: The changing landscape of the regulatory approval process Elodie Baumfeld Andre, Robert F. Reynolds, Patrick Caubel et al. · Pharmacoepidemiology and Drug Safety Open access	10 Dec 2019	265
5	Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative Tellen D. Bennett et al. · JAMA Network Open Open access169 authors	13 Jul 2021	252
6	Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden Rossella Elena Nappi, Robin Kroll, Emad J. Siddiqui et al. · Menopause The Journal of The North American Menopause Society Open access	24 May 2021	229
7	Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study Ruijun Chen, Marc A. Suchard, Harlan M. Krumholz et al. · Hypertension Open access	26 Jul 2021	193
8	Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study Jennifer C. E. Lane et al. · The Lancet Rheumatology Open access	21 Aug 2020	154
9	Strategies for effective mosquito control in constructed treatment wetlands R. L. Knight, William E. Walton, George F. O’Meara et al. · Ecological Engineering	Dec 2003	149
10	Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study Jennifer C. E. Lane et al. · medRxiv PreprintOpen access	10 Apr 2020	133
11	Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis Daniel R. Morales et al. · The Lancet Digital Health Open access	18 Dec 2020	130
12	Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms Mehmet Burcu, Nancy A Dreyer, Jessica Myers Franklin et al. · Pharmacoepidemiology and Drug Safety Open access	11 Mar 2020	125
13	Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals Stephen M. Kissler, Joseph R. Fauver, Christina DeFilippo Mack et al. · medRxiv PreprintOpen access	19 Feb 2021	115
14	Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making Grammati Sarri, Elisabetta Patorno, Hongbo Yuan et al. · BMJ Evidence-Based Medicine ReviewOpen access	9 Dec 2020	114
15	Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study Edward Burn, Talita Duarte‐Salles, Sergio Fernández‐Bertolín et al. · The Lancet Infectious Diseases Open access	13 May 2022	113
16	Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study Edward Burn et al. · Nature Communications Open access	6 Oct 2020	107
17	The effect of imposed and self-selected computer monitor height on posture and gaze angle Robin J. Burgess-Limerick, A. Plooy, Dennis R. Ankrum · Clinical Biomechanics	Dec 1998	102
18	Incidence of Lower Extremity Injury in the National Football League: 2015 to 2018 Christina DeFilippo Mack, Richard W. Kent, Michael J. Coughlin et al. · The American Journal of Sports Medicine	2 Jun 2020	100
19	Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable Nancy A Dreyer · Therapeutic Innovation & Regulatory Science Open access	20 Mar 2018	96
20	Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation Wallis C. Y. Lau, Carmen Olga Torre, Kenneth K. C. Man et al. · Annals of Internal Medicine	31 Oct 2022	94
21	Viral dynamics of acute SARS-CoV-2 infection Stephen M. Kissler, Joseph R. Fauver, Christina DeFilippo Mack et al. · medRxiv PreprintOpen access	23 Oct 2020	94
22	Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study James A. Hay et al. · medRxiv PreprintOpen access	14 Jan 2022	86
23	Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey Rossella Elena Nappi, Emad J. Siddiqui, Lora Todorova et al. · Maturitas Open access	24 Sep 2022	79
24	Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials Dony Patel, Fiona Grimson, Elena Mihaylova et al. · Value in Health Open access	8 Jun 2021	75
25	Comparison of Outcomes of Percutaneous Arteriovenous Fistulae Creation by Ellipsys and WavelinQ Devices Robert Shahverdyan, Gerald A. Beathard, Nasir Mushtaq et al. · Journal of Vascular and Interventional Radiology Open access	11 Aug 2020	72
26	Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials John D. Seeger, Kourtney J. Davis, Michelle R. Iannacone et al. · Pharmacoepidemiology and Drug Safety Open access	23 Sep 2020	69
27	Information Security Threats and Practices in Small Businesses Shannon Keller, Anne Powell, Ben Horstmann et al. · Information Systems Management	Mar 2005	68
28	The National COVID Cohort Collaborative: Clinical Characterization and Early Severity Prediction Tellen D. Bennett et al. · medRxiv PreprintOpen access	13 Jan 2021	64
29	AgileEVM - Earned Value Management in Scrum Projects T. Sulaiman, B. Barton, Tim Blackburn Conference paper	8 Aug 2006	64
30	Long-term phosphorus removal in Florida aquatic systems dominated by submerged aquatic vegetation R. L. Knight, Binhe Gu, Ronald A. Clarke et al. · Ecological Engineering	Mar 2003	63
31	Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US Xintong Li, Edward Burn, Talita Duarte‐Salles et al. · BMJ Open access	26 Oct 2022	61
32	Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting Nicole L. Pratt, Christina DeFilippo Mack, Anne Marie Meyer et al. · Pharmacoepidemiology and Drug Safety	17 Nov 2019	61
33	Finding undiagnosed patients with hepatitis C infection: an application of artificial intelligence to patient claims data Orla Doyle, Nadejda Leavitt, John Rigg · Scientific Reports Open access	29 Jun 2020	59
34	Methods of the National Collegiate Athletic Association Injury Surveillance Program, 2014–2015 Through 2018–2019 Avinash S. Chandran, Sarah N. Morris, Erin B. Wasserman et al. · Journal of Athletic Training Open access	Jul 2021	58
35	Lessons on Data Collection and Curation From the NFL Injury Surveillance Program Nancy A Dreyer, Christina DeFilippo Mack, Robert B. Anderson et al. · Sports Health A Multidisciplinary Approach Open access	2 Jul 2019	56
36	Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study Anastasiya Nestsiarovich, Jenna Reps, Michael Edwin Matheny et al. · Translational Psychiatry Open access	20 Dec 2021	54
37	COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries Eng Hooi Tan et al. · Lara D. Veeken Open access	11 Mar 2021	54
38	Dog Walking and the Social Impact of the COVID-19 Pandemic on Loneliness in Older Adults Dawn Celeste Carr, Erika Friedmann, Nancy R. Gee et al. · Animals Open access	22 Jun 2021	53
39	Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma Bruno Sangro, Peter R. Galle, Robin Kate Kelley et al. · Journal of Clinical Oncology Open access	28 May 2024	49
40	Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network study Edward Burn et al. · medRxiv PreprintOpen access	25 Apr 2020	48
41	Effects of reducing sedentary behaviour by increasing physical activity, on cognitive function, brain function and structure across the lifespan: a systematic review and meta-analysis Natan Feter et al. · British Journal of Sports Medicine ReviewOpen access	28 Aug 2024	47
42	Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study Jennifer C. E. Lane et al. · Lara D. Veeken Open access	25 Nov 2020	47
43	The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study Victoria M. Divino, Jennifer Schranz, Maureen Early et al. · Current Medical Research and Opinion	Oct 2019	47
44	Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas Robert Shahverdyan, Gerald A. Beathard, Nasir Mushtaq et al. · American Journal of Kidney Diseases Open access	Mar 2021	46
45	Quantification of missing prescriptions in commercial claims databases: results of a cohort study Maria Soledad Cepeda, Daniel Fife, Michel Denarié et al. · Pharmacoepidemiology and Drug Safety Open access	25 Jan 2017	46
46	Efficacy and safety of anti-calcitonin gene-related peptide monoclonal antibodies for treatment of chronic migraine: A systematic review and network meta-analysis Prashant Soni, Evanka Chawla · Clinical Neurology and Neurosurgery Review	13 Aug 2021	44
47	Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients Seng Chan You, Harlan M. Krumholz, Marc A. Suchard et al. · Hypertension Open access	29 Mar 2021	44
48	Redefining success: designing systemic sustainable strategies Alexander Laszlo, Kathia Castro Laszlo, Halim Dunsky · Systems Research and Behavioral Science	14 Jul 2009	44
49	Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes Rohan Khera et al. · Journal of the American College of Cardiology Open access	26 Aug 2024	43
50	Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic Hao Luo, Wallis C. Y. Lau, Yi Chai et al. · JAMA Psychiatry Open access	25 Jan 2023	42

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.